Welcome to Scop3P

Search for the desired protein with Uniprot accession, protein name/keyword, ProteomeXchange ID or PDB id

Ex.: O00571, ddx3x (keyword), ATP-dependent RNA helicase DDX3X, PXD000680 or 3JRV

  • Zoom in and zoom out (both with mouse and buttons on the right top corner) to see modificationson the protein
  • Slide the chart to see other modifications (both with mouse and buttons on the right topcorner)
  • Hover on the modification to see more information and position on the structure.
PDB 
 AlphaFold
Phospho-sites

Showing 13 results

Swiss-Prot Position Modification Source Evidence Singly phosphorylated
16 PhosphoS UP, PRIDE Combined
24 PhosphoT UP, PRIDE Combined
29 PhosphoS UP, PRIDE Combined
46 PhosphoS PRIDE yes
110 PhosphoY PRIDE yes
147 PhosphoS UP, PRIDE Combined yes
194 PhosphoY UP Combined
226 PhosphoY PRIDE yes
361 PhosphoS UP, PRIDE Combined yes
363 PhosphoS UP, PRIDE Combined yes
481 PhosphoS PRIDE yes
548 PhosphoT PRIDE
554 PhosphoY PRIDE

3D structure is not available

Display Settings

Hover over to see the values, zoom (in/out) or drag by using the mouse pointer.

Phosphorylated amino acids are colored red on the inner ring.

The first amino acid of the protein sequence is colored darker on each ring.

Phospho peptides

Showing 20 results

Sequence Modified position (Swiss-Prot) Peptide start Peptide end Modified position (Peptide) Number of projects
16 7 31 10 13
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD001060 58 Fe-IMAC column based phospho enrichment Homo sapiens (Human) PARTIAL 2015-08-19 Epithelial cell -
PXD004252 19 Modulating the selectivity of affinity absorbents to multi-phosphopeptides by a novel competitive substitution strategy Homo sapiens (Human) PARTIAL 2016-08-03 cell culture -
PXD000474 8 Simulated phosphopeptide spectral library for confident site localization Homo sapiens (Human) PARTIAL 2015-03-17 HeLa cell -
PXD002057 3 Proteomic analysis identifies novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapy Homo sapiens (Human) COMPLETE 2016-02-22 cell culture -
PXD006482 3 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer Homo sapiens (Human) COMPLETE 2017-09-01 kidney -
PXD005366 15 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture -
PXD001550 43 Human CRC cell line baseline phosphoproteomics Homo sapiens (Human) PARTIAL 2015-04-15 cell culture -
PXD002394 9 Proteomic and phosphoproteomic analysis of cisplatin resistance in patient derived serous ovarian cancer Homo sapiens (Human) PARTIAL 2017-05-02 cell suspension culture -
PXD000680 56 Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination Homo sapiens (Human) COMPLETE 2014-04-15 HeLa cell,HEK-293 cell
PXD000836 14 HOPE-fixation of lung tissue allows retrospective proteome and phosphoproteome studies Homo sapiens (Human) PARTIAL 2014-05-22 lung -
PXD002436 5 Monitoring cellular phosphorylation signaling pathways into chromatin and down to the gene level Homo sapiens (Human) COMPLETE 2015-11-09 HeLa cell -
PXD001546 21 Reproducibility of label-free single-shot phosphoproteomics applied to CRC cell lines Homo sapiens (Human) PARTIAL 2015-04-15 cell culture -
PXD004415 6 Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cells Homo sapiens (Human) COMPLETE 2017-05-11 T lymphocyte -
16 9 31 8 18
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD001060 31 Fe-IMAC column based phospho enrichment Homo sapiens (Human) PARTIAL 2015-08-19 Epithelial cell -
PXD004252 7 Modulating the selectivity of affinity absorbents to multi-phosphopeptides by a novel competitive substitution strategy Homo sapiens (Human) PARTIAL 2016-08-03 cell culture -
PXD000474 5 Simulated phosphopeptide spectral library for confident site localization Homo sapiens (Human) PARTIAL 2015-03-17 HeLa cell -
PXD004940 17 Performance of the Orbitrap Fusion Lumos Tribrid in single-shot analyses of human samples Homo sapiens (Human) PARTIAL 2017-03-09 HeLa cell
PXD003531 119 Proteomics of Primary cells derived from Ovarian Cancer Homo sapiens (Human) PARTIAL 2017-04-03 primary cell -
PXD002255 1 Enrichment strategy for searching missing protein Homo sapiens (Human) COMPLETE 2015-07-14 cell culture,blood serum -
PXD001333 11 Anion-Exchange Chromatography of Tryptic and Phosphopeptides: WAX vs. SAX and AEX vs. ERLIC Homo sapiens (Human) PARTIAL 2015-04-23 HeLa cell -
PXD006482 4 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer Homo sapiens (Human) COMPLETE 2017-09-01 kidney -
PXD005366 173 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture -
PXD001550 24 Human CRC cell line baseline phosphoproteomics Homo sapiens (Human) PARTIAL 2015-04-15 cell culture -
PXD004452 53 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon -
PXD002394 10 Proteomic and phosphoproteomic analysis of cisplatin resistance in patient derived serous ovarian cancer Homo sapiens (Human) PARTIAL 2017-05-02 cell suspension culture -
PXD000680 39 Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination Homo sapiens (Human) COMPLETE 2014-04-15 HeLa cell,HEK-293 cell -
PXD000836 3 HOPE-fixation of lung tissue allows retrospective proteome and phosphoproteome studies Homo sapiens (Human) PARTIAL 2014-05-22 lung -
PXD000612 61 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
PXD004415 9 Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cells Homo sapiens (Human) COMPLETE 2017-05-11 T lymphocyte -
PXD002436 3 Monitoring cellular phosphorylation signaling pathways into chromatin and down to the gene level Homo sapiens (Human) COMPLETE 2015-11-09 HeLa cell -
PXD001546 14 Reproducibility of label-free single-shot phosphoproteomics applied to CRC cell lines Homo sapiens (Human) PARTIAL 2015-04-15 cell culture -
16 9 27 8 6
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD000612 328 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
PXD004940 3 Performance of the Orbitrap Fusion Lumos Tribrid in single-shot analyses of human samples Homo sapiens (Human) PARTIAL 2017-03-09 HeLa cell -
PXD003531 100 Proteomics of Primary cells derived from Ovarian Cancer Homo sapiens (Human) PARTIAL 2017-04-03 primary cell -
PXD001333 32 Anion-Exchange Chromatography of Tryptic and Phosphopeptides: WAX vs. SAX and AEX vs. ERLIC Homo sapiens (Human) PARTIAL 2015-04-23 HeLa cell
PXD005366 45 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture -
PXD004452 34 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon -
24 9 31 16 3
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD000612 9 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
PXD001333 4 Anion-Exchange Chromatography of Tryptic and Phosphopeptides: WAX vs. SAX and AEX vs. ERLIC Homo sapiens (Human) PARTIAL 2015-04-23 HeLa cell
PXD000680 1 Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination Homo sapiens (Human) COMPLETE 2014-04-15 HeLa cell,HEK-293 cell -
24 9 27 16 2
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD000612 14 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
PXD001333 3 Anion-Exchange Chromatography of Tryptic and Phosphopeptides: WAX vs. SAX and AEX vs. ERLIC Homo sapiens (Human) PARTIAL 2015-04-23 HeLa cell
29 9 31 21 2
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD000612 2 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture
PXD001333 2 Anion-Exchange Chromatography of Tryptic and Phosphopeptides: WAX vs. SAX and AEX vs. ERLIC Homo sapiens (Human) PARTIAL 2015-04-23 HeLa cell -
46 40 50 7 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD000612 2 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture
46 42 50 5 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD000612 7 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture
46 42 62 5 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD004415 1 Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cells Homo sapiens (Human) COMPLETE 2017-05-11 T lymphocyte
110 106 120 5 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD001565 2 Evaluation of phospho-tyrosine antibodies for label-free phosphoproteomics Homo sapiens (Human) PARTIAL 2015-12-09 colon,brain
110 108 119 3 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD000612 1 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture
147 142 160 6 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD004452 1 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon
147 144 160 4 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD000612 1 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture
226 220 228 7 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD000612 21 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture
361 351 369 11 2
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD000612 1 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
PXD006482 1 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer Homo sapiens (Human) COMPLETE 2017-09-01 kidney
361 358 369 4 9
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD001060 3 Fe-IMAC column based phospho enrichment Homo sapiens (Human) PARTIAL 2015-08-19 Epithelial cell -
PXD000612 9 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture -
PXD003531 4 Proteomics of Primary cells derived from Ovarian Cancer Homo sapiens (Human) PARTIAL 2017-04-03 primary cell -
PXD006482 4 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer Homo sapiens (Human) COMPLETE 2017-09-01 kidney -
PXD002286 26 Phospo-proteomic profiling of Castration Resistant Prostate Cancer Homo sapiens (Human) PARTIAL 2016-08-19 - -
PXD005366 9 Robust, sensitive and automated phosphopeptide enrichment optimized for low sample amounts applied to primary hippocampal neurons Homo sapiens (Human),Rattus norvegicus (Rat) PARTIAL 2016-12-14 cell culture -
PXD004452 4 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon -
PXD001550 1 Human CRC cell line baseline phosphoproteomics Homo sapiens (Human) PARTIAL 2015-04-15 cell culture -
PXD000680 4 Stable isotope labeling of phosphoproteins for large-scale phosphorylation rate determination Homo sapiens (Human) COMPLETE 2014-04-15 HeLa cell,HEK-293 cell
363 358 369 6 3
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD003531 4 Proteomics of Primary cells derived from Ovarian Cancer Homo sapiens (Human) PARTIAL 2017-04-03 primary cell -
PXD002286 7 Phospo-proteomic profiling of Castration Resistant Prostate Cancer Homo sapiens (Human) PARTIAL 2016-08-19 -
PXD004452 1 HeLa proteome of 12,250 protein-coding genes Homo sapiens (Human) PARTIAL 2017-06-12 liver,colon -
481 479 509 3 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD000612 1 Ultra-deep human phosphoproteome reveals different regulatory nature of Tyr and Ser/Thr-based signaling Homo sapiens (Human) PARTIAL 2014-08-06 cell culture
548 546 556 3 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD003198 3 Characterisation of pancreatic ductal adenocarcinoma subtypes by global phosphotyrosine profiling Homo sapiens (Human) PARTIAL 2016-06-09 pancreatic cell line
554 546 556 9 1
ProteomeXchange accession Peptide frequency Project Title Species Submission Type Publication Date Tissues USI
PXD003198 3 Characterisation of pancreatic ductal adenocarcinoma subtypes by global phosphotyrosine profiling Homo sapiens (Human) PARTIAL 2016-06-09 pancreatic cell line

Structures

Showing 17 results

PDB id Chain Method Resolution Stoichiometry Interfacing Molecule/Chain Complex Formation Significance Score (CSS) P-sites View Structure
5L4K Z EM 4.5 Monomer N 0.0 16, 24, 29, 46, 110, 147, 194, 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
16 16 SER C 0.31 56.29777908325195 0.0
24 24 THR H 0.26 94.12797546386719 0.0
29 29 SER C 0.3 34.665496826171875 0.0
46 46 SER H 0.94 67.88499450683594 0.0
110 110 TYR H 0.96 3.997272253036499 0.0
147 147 SER C 1.0 70.47722625732422 0.0
194 194 TYR H 1.0 81.62626647949219 0.0
226 226 TYR C 0.96 49.098793029785156 0.0
361 361 SER C 1.0 68.5958023071289 0.0
363 363 SER C 1.0 30.29779052734375 0.0
481 481 SER H 0.91 0.0 0.0
548 548 THR C 0.83 52.61423873901367 0.0
554 554 TYR H 0.96 22.39576530456543 0.0
5VHF f EM 5.699999809265137 Monomer B 0.0 16, 24, 29, 46, 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
16 16 SER C 0.31 55.63959503173828 0.0
24 24 THR H 0.26 32.46432113647461 0.0
29 29 SER H 0.3 39.665374755859375 0.0
46 46 SER H 0.94 92.92910766601562 0.0
226 226 TYR H 0.96 164.53909301757812 0.0
361 361 SER C 1.0 6.940981864929199 0.0
363 363 SER C 1.0 77.57479858398438 0.0
481 481 SER H 0.91 6.700530052185059 0.0
548 548 THR C 0.83 71.09725952148438 0.0
554 554 TYR H 0.96 40.67543411254883 0.0
5VHH f EM 6.099999904632568 Monomer B 0.0 16, 24, 29, 46, 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
16 16 SER C 0.31 76.35401916503906 0.0
24 24 THR H 0.26 31.88068962097168 0.0
29 29 SER H 0.3 40.301212310791016 0.0
46 46 SER H 0.94 93.75990295410156 0.0
226 226 TYR H 0.96 166.9045867919922 0.0
361 361 SER H 1.0 12.131025314331055 0.0
363 363 SER C 1.0 77.16967010498047 0.0
481 481 SER H 0.91 15.81114673614502 0.0
548 548 THR C 0.83 70.96881103515625 0.0
554 554 TYR H 0.96 41.63334655761719 0.0
5VHI f EM 6.800000190734863 Monomer B 0.0 16, 24, 29, 46, 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
16 16 SER C 0.31 81.41071319580078 0.0
24 24 THR H 0.26 45.299476623535156 0.0
29 29 SER H 0.3 54.201568603515625 0.0
46 46 SER H 0.94 82.2757797241211 0.0
226 226 TYR H 0.96 161.66180419921875 0.0
361 361 SER H 1.0 19.537668228149414 0.0
363 363 SER H 1.0 93.21842193603516 0.0
481 481 SER H 0.91 21.223873138427734 0.0
548 548 THR C 0.83 76.73723602294922 0.0
554 554 TYR H 0.96 41.86468505859375 0.0
5VHN f EM 7.300000190734863 Monomer B 0.0 16, 24, 29, 46, 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
16 16 SER C 0.31 56.8405876159668 0.0
24 24 THR H 0.26 31.910371780395508 0.0
29 29 SER H 0.3 41.06555938720703 0.0
46 46 SER H 0.94 91.74136352539062 0.0
226 226 TYR H 0.96 167.2003173828125 0.0
361 361 SER C 1.0 8.16091251373291 0.0
363 363 SER C 1.0 78.9612808227539 0.0
481 481 SER H 0.91 13.205770492553711 0.0
548 548 THR C 0.83 72.34220886230469 0.0
554 554 TYR H 0.96 41.71762466430664 0.0
5VHR f EM 7.699999809265137 Monomer B 0.0 16, 24, 29, 46, 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
16 16 SER C 0.31 61.21707534790039 0.0
24 24 THR H 0.26 65.14391326904297 0.0
29 29 SER H 0.3 45.4244499206543 0.0
46 46 SER H 0.94 92.81025695800781 0.0
226 226 TYR H 0.96 167.8172607421875 0.0
361 361 SER C 1.0 22.209609985351562 0.0
363 363 SER C 1.0 81.95408630371094 0.0
481 481 SER H 0.91 6.231801509857178 0.0
548 548 THR C 0.83 78.03118133544922 0.0
554 554 TYR H 0.96 35.199317932128906 0.0
5VHM f EM 8.300000190734863 Monomer B 0.0 16, 24, 29, 46, 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
16 16 SER C 0.31 87.18778991699219 0.0
24 24 THR H 0.26 42.813167572021484 0.0
29 29 SER H 0.3 47.150203704833984 0.0
46 46 SER H 0.94 95.55583190917969 0.0
226 226 TYR H 0.96 163.5438232421875 0.0
361 361 SER C 1.0 14.791341781616211 0.0
363 363 SER C 1.0 74.35061645507812 0.0
481 481 SER H 0.91 19.08102798461914 0.0
548 548 THR C 0.83 63.766746520996094 0.0
554 554 TYR H 0.96 38.87236404418945 0.0
5VHO f EM 8.300000190734863 Monomer B 0.0 16, 24, 29, 46, 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
16 16 SER C 0.31 80.58311462402344 0.0
24 24 THR H 0.26 48.81924819946289 0.0
29 29 SER H 0.3 39.1969108581543 0.0
46 46 SER H 0.94 94.73192596435547 0.0
226 226 TYR H 0.96 157.1435546875 0.0
361 361 SER C 1.0 28.370038986206055 0.0
363 363 SER C 1.0 77.10667419433594 0.0
481 481 SER H 0.91 16.5178279876709 0.0
548 548 THR C 0.83 68.19544219970703 0.0
554 554 TYR H 0.96 36.50484848022461 0.0
5VHQ f EM 8.899999618530273 Monomer B 0.0 16, 24, 29, 46, 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
16 16 SER C 0.31 63.86821365356445 0.0
24 24 THR H 0.26 42.90583419799805 0.0
29 29 SER H 0.3 39.0703125 0.0
46 46 SER H 0.94 95.77276611328125 0.0
226 226 TYR H 0.96 164.8136749267578 0.0
361 361 SER C 1.0 8.050870895385742 0.0
363 363 SER C 1.0 81.55028533935547 0.0
481 481 SER H 0.91 5.799606800079346 0.0
548 548 THR C 0.83 74.5606689453125 0.0
554 554 TYR H 0.96 32.44308853149414 0.0
5LN3 Z EM 6.800000190734863 Monomer H 0.0 110, 147, 194, 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
110 110 TYR H 0.96 66.47135162353516 0.0
147 147 SER C 1.0 86.1089859008789 0.0
194 194 TYR H 1.0 79.56903839111328 0.0
226 226 TYR H 0.96 33.98468780517578 0.0
361 361 SER C 1.0 29.536964416503906 0.0
363 363 SER C 1.0 69.51702117919922 0.0
481 481 SER H 0.91 2.843825578689575 0.0
548 548 THR C 0.83 0.0 0.0
554 554 TYR H 0.96 3.435412645339966 0.0
5VHP f EM 7.900000095367432 Monomer B 0.0 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
226 226 TYR H 0.96 163.80487060546875 0.0
361 361 SER C 1.0 15.662216186523438 0.0
363 363 SER C 1.0 77.9704818725586 0.0
481 481 SER H 0.91 15.671868324279785 0.0
548 548 THR C 0.83 69.98546600341797 0.0
554 554 TYR H 0.96 40.75156784057617 0.0
5VHJ f EM 8.5 Monomer B 0.0 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
226 226 TYR H 0.96 161.42666625976562 0.0
361 361 SER H 1.0 27.657413482666016 0.0
363 363 SER C 1.0 77.07962799072266 0.0
481 481 SER H 0.91 13.481158256530762 0.0
548 548 THR C 0.83 71.227783203125 0.0
554 554 TYR H 0.96 40.39289855957031 0.0
5VHS f EM 8.800000190734863 Monomer B 0.0 226, 361, 363, 481, 548, 554
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
226 226 TYR H 0.96 161.55691528320312 0.0
361 361 SER H 1.0 11.214052200317383 0.0
363 363 SER C 1.0 76.84358215332031 0.0
481 481 SER H 0.91 14.613541603088379 0.0
548 548 THR C 0.83 64.14749908447266 0.0
554 554 TYR H 0.96 31.7170352935791 0.0
5T0G f EM 4.400000095367432 Monomer A 0.0
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
194 35 TYR H 1.0 56.18169021606445 0.0
226 67 TYR H 0.96 63.7590446472168 0.0
361 202 SER H 1.0 64.92594909667969 0.0
363 204 SER H 1.0 26.980976104736328 0.0
481 322 SER H 0.91 0.9616173505783081 0.0
548 389 THR C 0.83 34.47631072998047 0.0
554 395 TYR C 0.96 4.326208114624023 0.0
5T0H f EM 6.800000190734863 Monomer B 0.0
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
194 35 TYR H 1.0 58.36787033081055 0.0
226 67 TYR H 0.96 57.18125534057617 0.0
361 202 SER H 1.0 69.89141845703125 0.0
363 204 SER H 1.0 36.30268859863281 0.0
481 322 SER H 0.91 0.8926822543144226 0.0
548 389 THR C 0.83 38.29368591308594 0.0
554 395 TYR H 0.96 4.294369697570801 0.0
5T0J f EM 8.0 Monomer B 0.0
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
194 35 TYR H 1.0 54.58366012573242 0.0
226 67 TYR H 0.96 62.00630187988281 2.5062220096588135
361 202 SER H 1.0 72.31852722167969 0.0
363 204 SER H 1.0 35.079917907714844 0.0
481 322 SER H 0.91 1.7475318908691406 0.0
548 389 THR C 0.83 36.104393005371094 0.0
554 395 TYR C 0.96 4.2947821617126465 0.0
5T0I f EM 8.0 Monomer B 0.0
Swiss-Prot position PDB position Residue Secondary Structure Conserved Scale Accessible surface area Buried surface area
194 35 TYR H 1.0 55.13938522338867 0.0
226 67 TYR H 0.96 56.32352066040039 0.0
361 202 SER H 1.0 65.80984497070312 0.0
363 204 SER H 1.0 35.6888427734375 0.0
481 322 SER H 0.91 1.04134202003479 0.0
548 389 THR C 0.83 37.68067169189453 0.0
554 395 TYR C 0.96 5.800629615783691 0.0

Mutations

Showing 3 results

Swiss-Prot Position Amino acid (Wild type) Amino acid (Variant) Variant Type Disease
176 A T Polymorphism
313 E D Polymorphism
724 N Y Polymorphism